For example, the Journal of Managed Care and Specialty Pharmacy found that increased cost sharing above $100 was associated with up to 75% abandonment rate for certain specialty drugs. This suggests that Cost is a prevailing consideration for patients [in] medication purchasing. I think it's fair to say that none of us want to see patients abandoning necessary prescriptions due to high costs. (00:30–00:36)
CLAIM
Asserts that cost is a major factor for patients when purchasing medication.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
